Home2022-10-27T08:45:05-04:00

Disseminating data and research
on Treat All in sub-Saharan Africa

Key data metrics from IeDEA sites in sub-Saharan Africa

  • Enrollment in care

  • Time to ART initiation

  • Pre-treatment CD4 count

  • Viral load suppression

ABOUT THE IeDEA TREAT ALL DASHBOARD

In late 2015, the World Health Organization (WHO) recommended universal treatment of all people living with HIV, regardless of CD4 count or disease stage. WHO’s expanded treatment recommendation—also known as “Treat All”—has dramatically improved access to life-saving treatment around the globe. The purpose of the IeDEA Treat All Dashboard is to disseminate “real world” service delivery data from sites participating in IeDEA, along with research related to Treat All implementation and outcomes.

Read More About Us

WHERE WE ARE

We compile data from HIV care and treatment service delivery sites participating in IeDEA in sub-Saharan Africa, including the subregions of Central, East, Southern and West Africa.

0
IeDEA regions in sub-Saharan Africa
0
Countries
>0
Clinics contributing data to IeDEA

1.4M people living with HIV ever enrolled at care and treatment sites in Africa participating in IeDEA

WHO Treat All guidelines expanded
WHO Treat All guidelines expanded
WHO Treat All guidelines expanded
WHO Treat All guidelines expanded
IeDEA site location

FEATURED DATA VISUALIZATIONS

Timely ART initiation among patients enrolling in care at IeDEA sites
(2010 – 2017)

Central Africa

WHO Treat All guidelines expanded

East Africa

WHO Treat All guidelines expanded

Southern Africa

WHO Treat All guidelines expanded

West Africa

WHO Treat All guidelines expanded
  • Initiated ART within 7 days
  • Initiated ART within 30 days
  • Initiated ART within 12 months
Explore All Data

IeDEA BLOG

RECENT PUBLICATIONS

Comparison of cohort characteristics in Central Africa International Epidemiology Databases to Evaluate AIDS and Demographic Health Surveys: Rwanda and Burundi
International Journal of STD & AIDS | 2021
Mageras A, Brazier E, Niyongabo T, Murenzi G, D'Amour Sinayobye J, Adedimeji AA, Twizere C, Kelvin EA, Anastos K, Nash D, Jones HE
A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART
Elife | 2021
Ujeneza EL, Ndifon W, Shawry S, Fatti G, Riou J, Davies MA, Nieuwoudt M; IeDEA-Southern Africa collaboration
Effects of national adoption of Treat-All guidelines on pre-ART CD4 testing and viral load monitoring after ART initiation: A regression discontinuity analysis
Clinical Infectious Diseases | 2021
Brazier E, Tymejczyk O, Zaniewski E, Egger M, Wools-Kaloustian K, Yiannoutsos CT, Jaquet A, Althoff KN, Lee JS, Caro-Vega Y, Luz PM, Tanuma J, Niyongabo T, Nash D of IeDEA
Improving methods to classify perinatal versus nonperinatal HIV acquisition in young adolescents 10-14 years of age
The Pediatric Infectious Disease Journal | 2021
Tsondai PR, Davies MA, Singtoroj T, Maxwell N, McGowan CC, Songtaweesin WN, Technau KG, Kariminia A, Chimbetete C, Succi RCM, Pinto J, Rouzier V, Luque MT, Sohn AH; IeDEA Consortium
See all publications
WHO Treat All guidelines expanded